With us today are Peter Homberg and Michael Sessano, CEO of SOMAI Pharmaceuticals, shedding light on the fresh insights from the International Cannabis Business Conference (ICBC) and illuminating key topics of discussion. We delved into the potential transformation of patients into customers within the ambit of Cannabis Cultivation Clubs. We explored the escalating interest in capital within Germany as the classification shifts towards a prescription model (RX) and contemplated the prospective ripple effect of German legalization on a pan-European level, guided by the principles of pillars 1 and 2!
"We will see an increase in prescription because its not an RX anymore!"
Lawyer at DENTONS
Over a period of more than two years, Peter Homberg, as Partner and Head of the European Cannabis Sector Group at Dentons, has been providing monthly updates to the European cannabis industry on the last Thursday of every month within 20 min as a DEEP-DIVE on a certain topic.
Happy watching!